Detail akcie KYOWA HAKKO online

Business Summary: Kyowa Kirin Co., Ltd., formerly Kyowa Hakko Kirin Co., Ltd. is a Japan-based company principally engaged in the manufacture and sale of medical drugs. The Company operates through two business segments. Pharmaceuticals segment conducts research, development, manufacture and sale of pharmaceuticals and other products. Bio-chemicals segment is involved in the research, development, manufacture and sale of pharmaceuticals and industrial raw materials mainly for amino acid and nucleic acid related substances, as well as healthcare products.
Financial Summary: BRIEF: For the nine months ended 30 September 2019, Kyowa Kirin Co Ltd revenues increased 14% to Y225.46B. Net income applicable to common stockholders excluding extraordinary items decreased 37% to Y26.91B. Revenues reflect Japan segment increase from Y43.69B to Y140.6B, Americas segment increase from Y3.73B to Y32.76B. Net income was offset by Sales Promotion Expense increase of 80% to Y17.88B (expense).